General Information of Drug (ID: DM8RY7G)

Drug Name
3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide Drug Info
Synonyms
CHEMBL567637; 135733-34-5; 1,2,5-Oxadiazole-3-carboxaldehyde, 4-phenyl-, 2-oxide; 3-formyl-4-phenyl-1,2,5-oxadiazole n2-oxide; ACMC-20mvvi; 3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide; CTK0F4054; DTXSID00438521; 3-Formyl-4-phenylfurazan 2-oxide; BDBM50300756
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
10352496
CAS Number
CAS 135733-34-5
TTD Drug ID
DM8RY7G

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fotemustine DMV62ED Solid tumour/cancer 2A00-2F9Z Approved [2]
Spermidine DMVJNFI Plaque psoriasis EA90.0 Phase 3 [2]
Golden phosphorous acetyletic compound 2 DMYJ15A N. A. N. A. Patented [3]
Terpyridineplatinum(II) complexe 3 DM54EFD N. A. N. A. Patented [3]
Terpyridineplatinum(II) complexe 4 DMOV86T N. A. N. A. Patented [3]
Golden phosphorous acetyletic compound 1 DMVAKUI N. A. N. A. Patented [3]
Acyl oxymethyl acrylamide ester derivative 1 DMXTUE1 N. A. N. A. Patented [3]
PMID27977313-Compound-18 DMIA3GH N. A. N. A. Patented [3]
Triazole gold complexe 1 DMCWES7 N. A. N. A. Patented [3]
4-aryl quinol derivative 2 DM7TW5Z N. A. N. A. Patented [3]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cytoplasmic thioredoxin reductase (TXNRD1) TTR7UJ3 TRXR1_HUMAN Inhibitor [1]

References

1 Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schis... J Med Chem. 2009 Oct 22;52(20):6474-83.
2 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3 Thioredoxin reductase inhibitors: a patent review.Expert Opin Ther Pat. 2017 May;27(5):547-556.